Trade Setup: October 25 | Lower Vix Attests To Non-volatile & More Linear Period

NDTV Profit 2022-10-25

Views 22

Trade Setup | Defence emerging as consensus trading/investing bet for the medium-term. #BQLive
Read: https://bit.ly/3F9ONIv
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Marginal Volatility In Trade Anticipated | Trade Setup: July 27
play
19:30

Marginal Volatility In Trade Anticipated | Trade Setup: July 27
Trade Setup For 22 February: Expect High Volatility In Trade
play
09:36

Trade Setup For 22 February: Expect High Volatility In Trade
Trade Setup: 3 August | Keep An Eye Out For Vix
play
14:45

Trade Setup: 3 August | Keep An Eye Out For Vix
Trade Setup: 12 September | Falling Vix & Benign Global Cues To Aid Upmove
play
11:47

Trade Setup: 12 September | Falling Vix & Benign Global Cues To Aid Upmove
Trade Setup: October 12 | Nifty PCR Stands At 0.73; Vix Above 20
play
10:34

Trade Setup: October 12 | Nifty PCR Stands At 0.73; Vix Above 20
Trade Setup: 6 October| India Vix Below 20 Augurs Well For Equity Sentiment
play
14:03

Trade Setup: 6 October| India Vix Below 20 Augurs Well For Equity Sentiment
Lower Tax Expenses Aid Laurus Lab's Profit
play
06:03

Lower Tax Expenses Aid Laurus Lab's Profit
Laurus Labs In Focus | Ask Profit | NDTV Profit
play
00:00

Laurus Labs In Focus | Ask Profit | NDTV Profit
Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
play
30:49

Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
play
21:37

Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
play
03:26

Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
Laurus Labs In Focus | Ask Profit | NDTV Profit
play
26:27

Laurus Labs In Focus | Ask Profit | NDTV Profit